The size of the Global Protein A Resins Market was worth USD 454.42 million in 2019 and estimated to be growing at a CAGR of 8.2%, to reach USD 673.9 million by 2024. The market is showcasing the evident potential in the mentioned forecasting period. Increasing research on monoclonal antibodies is expected to drive sales of Protein A resins over the forecast period.
Monoclonal antibodies can be defined as an antibody produced by a single clone of cells; the antibodies can be produced in large quantities in the laboratory. They can be used to carry drugs, toxins, or radioactive substances straight to cancer cells. Monoclonal antibodies have been showing promising results in the management of chronic diseases such as cancers and rheumatoid arthritis.
Growing demand for biosimilars and increasing investments in the development of biosimilar products are the major factors driving the market for monoclonal antibodies. However, increasing awareness about alternate methods to purify monoclonal antibodies is expected to hamper the Protein A Resins market.
Nonetheless, the limiting factors for this market are the availability of alternative methods of purification such as ultrafiltration, crystallization, high-pressure folding, and capillary electrophoresis. High prices influence both affordability and protein A resin adoption rates, which impact negatively on the growth of the industry.
The high cost of Protein A resin is also a major factor hindering the growth of the market.
Market players deliver innovative protein A resin products such as next-generation protein A resins for clinical trials, which is expected to drive demand in the pharmaceutical and biotechnology industries. On-going research in developing new techniques is also creating chances for the Protein A Resins Market to grow.
REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2018 – 2024 |
|
Base Year |
2018 |
|
Forecast Period |
2019 - 2024 |
|
Segments Covered |
By Product Type, Application, End User, Matrix Type and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Market Leaders Profiled |
GE Healthcare, Repligen Corporation, Novasep, Tosoh Bioscience, GenScript, Thermo Fisher Scientific, EMD Millipore and Expedeon Ltd. |
This research report on the Global Protein A Resins Market has been segmented & sub-segmented into the following categories and analyzed market size & forecast for each segment until 2024.
Protein A Resins Market - By Product Type:
On the basis of product type, the segment of Recombinant Protein A accounts for the largest share of the market. Recombinant protein A is produced in E. coli and functions in the same way as normal protein A resins. Nonetheless, the recombinant protein type is favored where there is less non-specific binding provided by another production origin.
Protein A Resins Market - By Application:
Among the mentioned applications, the category of Immunoprecipitation is expected to show the highest growth during the forecast period. In the research and development sector, immunoprecipitation is widely applicable. As protein A resins are used in immunoprecipitation techniques, it is predicted that their demand will go hand in hand with increasing demand for immunoprecipitation. The growing demand for therapeutic antibodies and high antibody research and development activities will also contribute to increasing the growth of the segment to some extent.
Protein A Resins Market - By Matrix Type:
On the basis of the matrix type, The Glass or Silica based matrix segment is expected to show significant growth over the forecast period owing to improved longevity, mechanical strength and ability to integrate high metal dopant absorption.
Protein A Resins Market - By End User:
On the basis of End User, Biopharmaceutical companies make extensive use of protein A resins to purify monoclonal antibodies with great alarm. The development by the biopharmaceutical industry of therapeutic monoclonal antibodies is expected to rise to meet its growing demand. As the production of monoclonal antibodies increases, the demand for protein A resins for large-scale purification will increase. The growing trend of outsourcing large-scale production to contract research organizations would also increase the growth of the Clinical Research Laboratories' end-user segment in the market.
Regional Analysis:
North America is the largest market for Protein A resin accounting for a share of approximately 37% due to a large number of investments in the development of monoclonal antibodies followed by Europe.
Asia Pacific region is estimated to be the fastest-growing region with a Compound Annual Growth Rate of XX% owing to a large number of untapped markets and growing awareness about the developments in the market
Companies leading the Global Protein A Resins Market profiled in the report are
Major Players in the market are entering into strategic agreements to develop raw materials required to manufacture Protein A resins.
Some of the key companies covered in the report are
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Product Type
5.1.1 Natural Protein A Resin
5.1.2 Recombinant Protein A Resin
5.2 By Application
5.2.1 Immunoprecipitation
5.2.2 Antibody Purification
5.3 By End Users
5.3.1 Biopharmaceutical Manufacturers
5.3.2 Clinical Research Laboratories
5.3.3 Academic Institutes
5.4 By Matrix Type
5.4.1 Glass or Silica
5.4.2 Agarose
5.4.3 Organic Polymer
6. Geographical Analysis
6.1 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.2 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.3 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 South Korea
6.4 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Mexico
6.4.4 Rest of Latin America
6.5 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 GE Healthcare
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Thermo Fisher Scientific
8.3 Repligen
8.4 Tosoh Bioscience
8.5 EMD Millipore
8.6 Novasep
8.7 GenScript
8.8 Expedeon Ltd
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
